183 related articles for article (PubMed ID: 15619779)
1. Management options for facial lipoatrophy.
Cofrancesco J; Brown T; Martins CR
AIDS Read; 2004 Dec; 14(12):639-40, 645-50. PubMed ID: 15619779
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated facial lipoatrophy--review of current therapy options.
Bechara FG; Sand M; Potthoff A; Altmeyer P; Brockmeyer NH;
Eur J Med Res; 2008 Mar; 13(3):93-9. PubMed ID: 18499554
[TBL] [Abstract][Full Text] [Related]
3. Restorative interventions for HIV facial lipoatrophy.
Carey D; Liew S; Emery S
AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
[TBL] [Abstract][Full Text] [Related]
4. [Facial lipodystrophy in patients with HIV infections troublesome to treat].
Walther RA
Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531
[TBL] [Abstract][Full Text] [Related]
5. Cost consequences of HIV-associated lipoatrophy.
Hornberger J; Rajagopalan R; Shewade A; Loutfy MR
AIDS Care; 2009 May; 21(5):664-71. PubMed ID: 19444676
[TBL] [Abstract][Full Text] [Related]
6. Treatment of facial lipoatrophy via autologous fat transfer.
Cohen G; Treherne A
J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
Sattler FR
Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
[TBL] [Abstract][Full Text] [Related]
8. Treatment of facial lipoatrophy in HIV-infected patients.
Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
[TBL] [Abstract][Full Text] [Related]
10. A comparison of lipoatrophy and aging: volume deficits in the face.
Coleman S; Saboeiro A; Sengelmann R
Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
[TBL] [Abstract][Full Text] [Related]
11. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.
Parruti G; Toro GM
BMC Infect Dis; 2005 Oct; 5():80. PubMed ID: 16202141
[TBL] [Abstract][Full Text] [Related]
12. Lipoatrophy: a new "scarlet letter".
Hoyt G
Surviv News (Atlanta Ga); 2004; 15(2):8, 19. PubMed ID: 15124576
[No Abstract] [Full Text] [Related]
13. Facial and limb fat loss: lipoatrophy.
Proj Inf Perspect; 2003 Oct; (36):11-2. PubMed ID: 14696569
[TBL] [Abstract][Full Text] [Related]
14. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
Ramon Y; Fodor L; Ullmann Y
Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
[TBL] [Abstract][Full Text] [Related]
15. Current treatment methods for combination antiretroviral therapy-induced lipoatrophy of the face.
Kadouch JA; van Rozelaar L; Karim RB; Hoekzema R
Int J STD AIDS; 2013 Sep; 24(9):685-94. PubMed ID: 23970569
[TBL] [Abstract][Full Text] [Related]
16. Relationship between lipoatrophy and quality of life.
Echavez M; Horstman W
AIDS Read; 2005 Jul; 15(7):369-75. PubMed ID: 16044579
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique.
Burnouf M; Buffet M; Schwarzinger M; Roman P; Bui P; Prévot M; Deleuze J; Morini JP; Franck N; Gorin I; Dupin N
Arch Dermatol; 2005 Oct; 141(10):1220-4. PubMed ID: 16230558
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
19. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
[TBL] [Abstract][Full Text] [Related]
20. Long-term complications of antiretroviral therapy: lipoatrophy.
Waters L; Nelson M
Int J Clin Pract; 2007 Jun; 61(6):999-1014. PubMed ID: 17504362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
